DJIA 15,898.09 237.91 1.52%
NASDAQ 4,320.10 53.26 1.25%
S&P 500 1,856.02 26.94 1.47%
market minute promo

Alkermes, Inc. (NASDAQ: ALKS)

31.85 0.66 (2.12%)

Quote as of


company name or ticker

Recent Quotes

ALKS $31.85 2.12%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $31.37
Previous Close $31.19
Daily Range $30.53 - $31.99
52-Week Range $27.78 - $80.71
Market Cap $4.8B
P/E Ratio -46.55
Dividend (Yield) $0.00 (0.0%)
Volume 1,047,027
Average Daily Volume 2,204,880
Current FY EPS -$1.09

Sector

Healthcare

Industry

Drug Makers

Alkermes, Inc. (ALKS) Description

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Website: http://www.alkermes.com/

News & Commentary

Why Did Biotech Fall Off a Cliff in January?

Biotech's decline doesn't signal the start of a bear market for the industry. Here's why.

Alkermes' ALKS 3831 in 2nd Phase III Study for Schizophrenia

Commit To Purchase Alkermes At $23, Earn 13.6% Annualized Using Options

Sum Up The Pieces: PDP Could Be Worth $45

Depression Target Aside, Alkermes Still Has Two Blockbuster Therapies In Its Pipeline

Alkermes Initiates Early-Stage Study on Alzheimer's Drug

4 Stocks That Punished Shareholders Last Week

Alkermes Hit 52-Week Low on Unfavorable Phase III Data

Forward Goes Backward For Alkermes

Why Alkermes, Scholastic, and MGIC Investment Slumped Today

These stocks fell even though the broader market managed to claw back some of its lost ground. Find out why.

See More ALKS News...

ALKS's Top Competitors

ALKS $31.85 (2.12%)
Current stock: ALKS
AMGN $142.09 (0.45%)
Current stock: AMGN
GILD $89.13 (2.03%)
Current stock: GILD
BIIB $243.36 (-0.71%)
Current stock: BIIB